NCT06509906
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06509906
Title M9466 in Combination With Topoisomerase 1 Inhibitors-based Regimens in Advanced Solid Tumors and Colorectal Cancer (DDRiver 511)
Acronym DDRiver 511
Recruitment Suspended
Gender both
Phase Phase I
Variant Requirements No
Sponsors EMD Serono Research & Development Institute, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ESP | AUS

Facility Status City State Zip Country Details
Sarah Cannon Research Institute at Health One Denver Colorado 80218 United States Details
Carolina BioOncology Institute, LLC - Cancer Therapy and Research Center Pennington New Jersey 08534 United States Details
Vanderbilt University - 150912667 Nashville Tennessee 37232 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030-4009 United States Details
Cancer Research SA Elizabeth Vale Australia Details
St George Private Hospital Kogarah Australia Details
Peter MacCallum Cancer Centre - Use the one with Account 2 VCCC Parkville Australia Details
National Cancer Center Hospital Chūōku Japan Details
Samsung Medical Center Seoul South Korea Details
Seoul National University Hospital Seoul South Korea Details
NEXT Barcelona - NEXT Barcelona Barcelona Spain Details
NEXT Madrid - Hospital Universitario Quironsalud Madrid Pozuelo de Alarcón Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field